AI Article Synopsis
- A study was conducted to assess the impact of metformin on patient outcomes after surgery for oral squamous cell carcinoma, involving 346 patients at Xiangya Hospital.
- Patients were divided into two groups: one receiving metformin post-surgery (71 patients) and a control group without it (275 patients), with follow-up data analyzed using statistical software.
- Results indicated that the group taking metformin experienced a significantly lower recurrence rate of cancer, especially among certain demographics such as males and those with certain tumor characteristics (P<0.05).
Article Abstract
Purpose: To investigate the effect of metformin on the prognosis of patients with oral squamous cell carcinoma after surgical treatment.
Methods: Three hundred and forty-six patients with oral squamous cell carcinoma after operation in Xiangya Hospital of Central South University from October 2015 to October 2016 were selected and divided into experimental group and control group. In the experimental group, 71 patients with oral squamous cell carcinoma received metformin after surgery. The control group included 275 patients without metformin after surgery of oral squamous cell carcinoma. The clinical follow-up results of patients in the two groups were compared. SPSS 21.0 software package was used to analyze the data.
Results: Compared with the control group, the recurrent rate of the experimental group was lower. The difference was more significant in male patients, patients with primary tongue tumor, patients with highly differentiated squamous cell carcinoma, patients with cervical lymph node metastasis, and patients with a history of chewing areca nut (P<0.05).
Conclusions: Metformin can decrease postoperative recurrent rate and metastatic rate of oral squamous cell carcinoma after surgery.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!